Amanda Simons

Amanda is a European and UK Patent Attorney based in our Oxford office and Head of the Chemistry and Pharmaceuticals Group. She works with many startup companies in the Oxford area and beyond to assist them in developing their IP. Amanda’s work focuses on the pharmaceutical and medtech sectors, including anti-microbials, re-purposed drugs, pharmaceutical formulations, medical sensors and other medical equipment, but she also has experience in a broad range of chemical technologies including sugar chemistry and alloys.

Amanda is known for her pragmatic approach to IP strategy and portfolio management. She is recommended by The Legal 500 and is ranked as an IP Star by Managing Intellectual Property, with clients commenting that Amanda “understands our needs and finds practical and strategic solutions to problems”. She is very experienced in assisting clients in freedom to operate investigations and due diligence projects. Amanda advises both those looking to invest in a new technology and those seeking investment.

In addition to her local client base, Amanda has many clients in China and visits China at least once a year, keeping her fully up-to-date with legal developments.

A further focus of Amanda’s work is representing clients at opposition before the European Patent Office, where she has acted in a number of high profile opposition cases. Amanda's experience extends to the defence of several pharmaceutical patents including those for sofosbuvir, Mozobil and eculizumab. She also has extensive experience in handling oppositions in blood coagulation therapies, dialysis, wound healing devices and materials.

In 2024 Amanda was recognised in Managing IP's Top 250 Women in IP. This special publication recognises some of the senior female IP practitioners in private practice who have performed exceptionally for their clients and firms across the year.

Amanda joined J A Kemp in 1998 and became a partner in 2008.